- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- Transrectal Ultrasound
- Device
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 40 Years to 85 Years · Male only
- Enrollment
- 1 participant
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2016
- U.S. locations
- 1
- States / cities
- Baltimore, Maryland
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Showing 145–168
of 184
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Urinary Calculi, Benign Prostatic Hyperplasia
- Interventions
- Flexiva Pulse High Power Single-Use Laser Fibers
- Device
- Lead sponsor
- Boston Scientific Corporation
- Industry
- Eligibility
- Not listed
- Enrollment
- 201 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2023
- U.S. locations
- 4
- States / cities
- Phoenix, Arizona • Miami, Florida • Orlando, Florida + 1 more
- Conditions
- Lower Urinary Tract Symptoms (LUTS)
- Interventions
- Placebo, Degarelix 10 mg, Degarelix 20 mg, Degarelix 30 mg
- Drug
- Lead sponsor
- Ferring Pharmaceuticals
- Industry
- Eligibility
- 50 Years and older · Male only
- Enrollment
- 404 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 15
- States / cities
- Homewood, Alabama • Mobile, Alabama • Newport Beach, California + 12 more
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- Gallium 68 Macro-aggregated albumin
- Drug
- Lead sponsor
- University of North Carolina, Chapel Hill
- Other
- Eligibility
- 40 Years and older · Male only
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 1
- States / cities
- Chapel Hill, North Carolina
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- Data collection
- Other
- Lead sponsor
- Urotronic Inc.
- Industry
- Eligibility
- Male only
- Enrollment
- 500 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2027
- U.S. locations
- 8
- States / cities
- Tampa, Florida • Kearney, Nebraska • Omaha, Nebraska + 5 more
- Conditions
- Kidney Stone, Benign Prostatic Hyperplasia
- Interventions
- WellPrept, Standard Care
- Other
- Lead sponsor
- Northwestern University
- Other
- Eligibility
- 18 Years to 100 Years
- Enrollment
- 300 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2027
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Benign Prostatic Hyperplasia (BPH)
- Interventions
- Treatment Device: The ALPFA Medical (ALPFA) GRAIL™ Pulsed Field Ablation (PFA) System, Control Device: Sham flexible cystoscopy
- Device
- Lead sponsor
- ALPFA Medical
- Industry
- Eligibility
- 45 Years and older · Male only
- Enrollment
- 250 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2032
- U.S. locations
- 18
- States / cities
- Mesa, Arizona • Sun City, Arizona • Tucson, Arizona + 15 more
- Conditions
- Benign Prostatic Hyperplasia (BPH)
- Interventions
- Adalimumab
- Drug
- Lead sponsor
- Endeavor Health
- Other
- Eligibility
- 45 Years to 80 Years · Male only
- Enrollment
- 70 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2024 – 2028
- U.S. locations
- 1
- States / cities
- Glenview, Illinois
- Conditions
- Benign Prostatic Hyperplasia, BPH, Lower Urinary Tract Symptoms (LUTS), LUTS
- Interventions
- NX-1207
- Drug
- Lead sponsor
- Nymox Corporation
- Industry
- Eligibility
- 45 Years and older · Male only
- Enrollment
- 160 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2014
- U.S. locations
- 17
- States / cities
- Laguna Beach, California • San Diego, California • Aventura, Florida + 14 more
- Conditions
- Calculi, Renal, Calculi, Urinary, Benign Prostatic Hyperplasia
- Interventions
- SOLTIVE Premium SuperPulsed Laser System
- Device
- Lead sponsor
- Olympus Corporation of the Americas
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 250 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Kansas City, Kansas
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- UroLift® System
- Device
- Lead sponsor
- NeoTract, Inc.
- Industry
- Eligibility
- 50 Years and older · Male only
- Enrollment
- 51 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2018
- U.S. locations
- 7
- States / cities
- San Diego, California • Daytona Beach, Florida • St. Petersburg, Florida + 4 more
- Conditions
- Hypogonadism, Benign Prostatic Hyperplasia
- Interventions
- Dutasteride, Testosterone gel, Placebo dutasteride
- Drug
- Lead sponsor
- University of Washington
- Other
- Eligibility
- 50 Years and older · Male only
- Enrollment
- 53 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2005 – 2010
- U.S. locations
- 1
- States / cities
- Seattle, Washington
- Conditions
- Prostatic Hyperplasia
- Interventions
- Prostate Embolization
- Device
- Lead sponsor
- John D Louie
- Other
- Eligibility
- 50 Years and older · Male only
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2028
- U.S. locations
- 1
- States / cities
- Stanford, California
- Conditions
- Benign Prostatic Hyperplasia (BPH)
- Interventions
- Prostate Artery Embolization
- Device
- Lead sponsor
- Northwestern University
- Other
- Eligibility
- 45 Years and older · Male only
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2022
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- UroLift
- Device
- Lead sponsor
- NeoTract, Inc.
- Industry
- Eligibility
- 45 Years and older · Male only
- Enrollment
- 12 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2019
- U.S. locations
- 1
- States / cities
- Austin, Texas
- Conditions
- Benign Prostatic Hyperplasia, Lower Urinary Tract Symptom
- Interventions
- Rezum System, Rigid Cystoscopy
- Device · Procedure
- Lead sponsor
- Boston Scientific Corporation
- Industry
- Eligibility
- 50 Years and older · Male only
- Enrollment
- 197 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2016
- U.S. locations
- 15
- States / cities
- Tucson, Arizona • Denver, Colorado • Aventura, Florida + 12 more
- Conditions
- Overactive Bladder
- Interventions
- Vibegron
- Drug
- Lead sponsor
- Urovant Sciences GmbH
- Industry
- Eligibility
- 45 Years and older · Male only
- Enrollment
- 276 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2022
- U.S. locations
- 31
- States / cities
- Huntsville, Alabama • Lincoln, California • Los Angeles, California + 26 more
- Conditions
- BPH, Benign Prostatic Hyperplasia
- Interventions
- SOLTIVE Thulium Laser, Standard of Care (Holmium Laser)
- Other
- Lead sponsor
- University of Kansas Medical Center
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2024
- U.S. locations
- 1
- States / cities
- Kansas City, Kansas
- Conditions
- Benign Prostatic Hypertrophy
- Interventions
- Ozarelix, Placebo
- Drug
- Lead sponsor
- Spectrum Pharmaceuticals, Inc
- Industry
- Eligibility
- 50 Years and older · Male only
- Enrollment
- 74 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2008
- U.S. locations
- 13
- States / cities
- Tucson, Arizona • Laguna Hills, California • Los Angeles, California + 10 more
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- UroLift™ System and Holmium Laser Enucleation of the Prostate (HoLEP)
- Other
- Lead sponsor
- University of Kansas Medical Center
- Other
- Eligibility
- 45 Years and older · Male only
- Enrollment
- 3 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2025
- U.S. locations
- 1
- States / cities
- Kansas City, Kansas
- Conditions
- Prostatic Hyperplasia, Prostate
- Interventions
- tadalafil, placebo
- Drug
- Lead sponsor
- Eli Lilly and Company
- Industry
- Eligibility
- 45 Years and older · Male only
- Enrollment
- 275 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2004 – 2005
- U.S. locations
- 1
- States / cities
- Chicago, Illinois
- Conditions
- Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms
- Interventions
- Talaporfin sodium, Placement of device in prostate urethra, Transurethral illumination with light emitting diodes (Litx™ BPH Device)
- Drug · Procedure · Device
- Lead sponsor
- Light Sciences Oncology
- Industry
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2011
- U.S. locations
- 6
- States / cities
- Anchorage, Alaska • Los Angeles, California • Portland, Oregon + 3 more
- Conditions
- Prostatic Hyperplasia
- Interventions
- dutasteride 0.5mg once daily for 4 years, tamsulosin 0.4mg once daily for 4 years
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 50 Years and older · Male only
- Enrollment
- 4,844 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003 – 2009
- U.S. locations
- 113
- States / cities
- Birmingham, Alabama • Columbiana, Alabama • Hoover, Alabama + 98 more
- Conditions
- Benign Prostatic Hyperplasia
- Interventions
- Prostatic Embolization with Embosphere Micropsheres
- Device
- Lead sponsor
- James B. Spies, MD
- Other
- Eligibility
- 50 Years to 90 Years · Male only
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2017
- U.S. locations
- 1
- States / cities
- Washington D.C., District of Columbia